Award
NIH Reporter #10890142
1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial
Recipient
Lurie Children's Hospital of Chicago
Award Amount
$408,351.00
Ceiling
$408,351.00
Awarded
August 06, 2024
Identifier
10890142
Federal grant for a Phase IIb clinical trial testing allogeneic human mesenchymal stem cell injections in patients with Hypoplastic Left Heart Syndrome, managed by Lurie Children's Hospital of Chicago and funded by NHLBI.
Description
A federal grant opportunity for a clinical trial involving MSC injections for HLHS patients, managed by Lurie Children's Hospital of Chicago, funded by the NHLBI. The project aims to assess safety and efficacy, with potential progression to Phase III trials.